Literature DB >> 16954399

Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo.

Julian A Guttman1, Fereshte N Samji, Yuling Li, A Wayne Vogl, B Brett Finlay.   

Abstract

It is widely accepted that tight junctions are altered during infections by attaching and effacing (A/E) pathogens. These disruptions have been demonstrated both in vitro and more recently in vivo. For in vivo experiments, the murine model of A/E infection with Citrobacter rodentium is the animal model of choice. In addition to effects on tight junctions, these bacteria also colonize the colon at high levels, efface colonocyte microvilli, and cause hyperplasia and inflammation. Although we have recently demonstrated that tight junctions are disrupted by C. rodentium, the issue of direct effects of bacteria on epithelial cell junctions versus the indirect effects of inflammation still remains to be clarified. Here, we demonstrate that during the C. rodentium infections, inflammation plays no discernible role in the alteration of tight junctions. The distribution of the tight junction proteins, claudin-1, -3, and -5, are unaffected in inflamed colon, and junctions appear morphologically unaltered when viewed by electron microscopy. Additionally, tracer molecules are not capable of penetrating the inflamed colonic epithelium of infected mice that have cleared the bacteria. Finally, infected colonocytes from mice exposed to C. rodentium for 14 days, which have high levels of bacterial attachment to colonocytes as well as inflammation, have characteristic, altered claudin localization whereas cells adjacent to infected colonocytes retain their normal claudin distribution. We conclude that inflammation plays no discernible role in tight junction alteration during A/E pathogenesis and that tight junction disruption in vivo appears dependent only on the direct intimate attachment of the pathogenic bacteria to the cells.

Entities:  

Mesh:

Year:  2006        PMID: 16954399      PMCID: PMC1695516          DOI: 10.1128/IAI.00721-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.

Authors:  C Rahner; L L Mitic; J M Anderson
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

Review 2.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 3.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

5.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

6.  Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria.

Authors:  B Kenny; M Jepson
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

7.  Inflammatory bowel disease is associated with changes of enterocytic junctions.

Authors:  N Gassler; C Rohr; A Schneider; J Kartenbeck; A Bach; N Obermüller; H F Otto; F Autschbach
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-07       Impact factor: 4.052

Review 8.  Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia.

Authors:  S A Luperchio; D B Schauer
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

9.  Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.

Authors:  Jean-Philippe Nougayrède; Michael S Donnenberg
Journal:  Cell Microbiol       Date:  2004-11       Impact factor: 3.715

10.  Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice.

Authors:  Takehiro Nitta; Masaki Hata; Shimpei Gotoh; Yoshiteru Seo; Hiroyuki Sasaki; Nobuo Hashimoto; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2003-05-12       Impact factor: 10.539

View more
  36 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  Redistribution of tight junction proteins during EPEC infection in vivo.

Authors:  Qiang Zhang; Qiurong Li; Chenyang Wang; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function.

Authors:  Grace Soong; Dane Parker; Mariah Magargee; Alice S Prince
Journal:  J Bacteriol       Date:  2007-12-28       Impact factor: 3.490

Review 4.  Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.

Authors:  Jarin Chun; Alice Prince
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

5.  Modulation of occluding junctions alters the hematopoietic niche to trigger immune activation.

Authors:  Rohan J Khadilkar; Wayne Vogl; Katharine Goodwin; Guy Tanentzapf
Journal:  Elife       Date:  2017-08-25       Impact factor: 8.140

6.  Barriers of Mucosal Entry of HIV/SIV.

Authors:  Ann M Carias; Thomas J Hope
Journal:  Curr Immunol Rev       Date:  2019

7.  Hyaluronan 35kDa treatment protects mice from Citrobacter rodentium infection and induces epithelial tight junction protein ZO-1 in vivo.

Authors:  Yeojung Kim; Sean P Kessler; Dana R Obery; Craig R Homer; Christine McDonald; Carol A de la Motte
Journal:  Matrix Biol       Date:  2016-11-11       Impact factor: 11.583

8.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Epithelial p38alpha controls immune cell recruitment in the colonic mucosa.

Authors:  Young Jun Kang; Motoyuki Otsuka; Arjen van den Berg; Lixin Hong; Zhe Huang; Xiurong Wu; Duan-Wu Zhang; Bruce A Vallance; Peter S Tobias; Jiahuai Han
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

Review 10.  Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.

Authors:  Jennifer K Beatty; Amol Bhargava; Andre G Buret
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.